For your patients
Frequently asked questions
VUITY™ contracts the iris sphincter muscle, constricting the pupil to improve near and intermediate visual acuity while maintaining some pupillary response to light.1 VUITY™ also contracts the ciliary muscle, and may shift the eye to a more myopic state.1
VUITY™ is indicated for the treatment of presbyopia in adults.1
The recommended dosage of VUITY™ is one drop in each eye once daily.1 If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.1
If more than one type of topical eye therapy is being used, they should be administered at least 5 minutes apart.1
Yes. However, contact lenses should be removed prior to the instillation of VUITY™ and patients should wait 10 minutes after dosing before reinserting them.1
VUITY™ was evaluated in 375 patients with presbyopia in two randomized, double-masked, vehicle-controlled studies (GEMINI 1 and GEMINI 2) of 30 days' duration.1 The most common adverse reactions reported in >5% of patients were headache and conjunctival hyperemia.1 Ocular adverse reactions reported in 1–5% of patients were blurred vision, eye pain, visual impairment, eye irritation, and increased lacrimation.1
Patients may pay as little as $79 per bottle of VUITY™.
VUITY™ is not covered by insurance, but your patients can use their HSA/FSA to pay for VUITY™.
VUITYTM speaker event
Hear from a renowned expert on how VUITY™ may benefit your patients.